Abstract
Endometrial cancer is the most common gynaecological cancer in the UK with rates rising steadily over the last four decades. Fortunately majority of them are diagnosed in early stages with good prognosis. A pathway to diagnosis is governed by NICE guidance and treatment by BGCS guideline. Assessment of suspected and treatment of confirmed endometrial cancer has several areas of heterogeneity due to the lack of clear evidence. Knowing the absolute musts and formulating the best strategies for the areas of grey evidence would offer best protection against potential litigations. In addition to these clinical pitfalls, importance of due diligence in communication and documentation has never been of a greater importance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence. Accessed Oct 2017.
National Institute for Health and Care Excellence (NICE). Suspected cancer: recognition and referral. NICE Guideline; 2015. http://www.nice.org.uk/guidance/ng12. Accessed Oct 2017.
British Gynaecological Cancer Society (BGCS). Uterine Cancer Guidelines: Recommendations for Practice; 2017.https://bgcs.org.uk/BGCS%20Endometrial%20Guidelines%202017.pdf. Accessed Oct 2017.
Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–36.
Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–51.
Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2017;(10). Art. No.: CD007585.
Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis. (Published erratum appears in Lancet 2010; 376: 594.). Lancet. 2010;375:1165–72.
Royal College of Obstetricians and Gynaecologists (RCOG), Sentinel Lymph Node Biopsy in Endometrial Cancer: Scientific Impact Paper No. 51; 2016. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/sip51/. Assessed Oct 2017.
Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017;18:384–92.
Royal College of Obstetricians and Gynaecologists (RCOG)/British Society of Gynaecological Endoscopy (BSGE) Joint Guideline Management of Endometrial Hyperplasia, Green-top Guideline No. 67; 2016. https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_67_endometrial_hyperplasia.pdf. Assessed Oct 2017.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Patel, A. (2018). Uterine Cancer. In: Jha, S., Ferriman, E. (eds) Medicolegal Issues in Obstetrics and Gynaecology. Springer, Cham. https://doi.org/10.1007/978-3-319-78683-4_67
Download citation
DOI: https://doi.org/10.1007/978-3-319-78683-4_67
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78682-7
Online ISBN: 978-3-319-78683-4
eBook Packages: MedicineMedicine (R0)